Jupiter Neurosciences(JUNS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

JUNS Jupiter Neurosciences

Pre-Mkt 07-16 06:47:17 EDT

0.1785

+0.0005

+0.28%

盘前0.1750

-0.0035-1.96%

04:41 EDT

High0.1825	Low0.1700	Vol401.13K
Open0.1740	D1 Closing0.1780	Amplitude7.02%
Mkt Cap8.61M	Tradable Cap4.81M	Total Shares48.22M
T/O70.46K	T/O Rate1.49%	Tradable Shares26.94M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"JUNS","market":"US","secType":"STK","nameCN":"Jupiter Neurosciences","latestPrice":0.1785,"timestamp":1784145600000,"preClose":0.178,"halted":0,"volume":401126,"hourTrading":{"tag":"盘前","latestPrice":0.175,"preClose":0.1785,"latestTime":"04:41 EDT","volume":4250,"amount":738.34995,"timestamp":1784191273878,"change":-0.0035,"changeRate":-0.019608,"amplitude":0.010084},"delay":0,"changeRate":0.0028089887640449463,"floatShares":26935400,"shares":48224100,"eps":-0.260986,"marketStatus":"Pre-Mkt","change":0.0005,"latestTime":"07-16 06:47:17 EDT","open":0.174,"high":0.1825,"low":0.17,"amount":70464.97408918,"amplitude":0.070225,"askPrice":0.2061,"askSize":100,"bidPrice":0.1601,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-0.260986,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1784208600000},"marketStatusCode":1,"adr":0,"listingDate":1733202000000,"exchange":"NASDAQ","adjPreClose":0.1785,"preHourTrading":{"tag":"盘前","latestPrice":0.175,"preClose":0.1785,"latestTime":"04:41 EDT","volume":4250,"amount":738.34995,"timestamp":1784191273878,"change":-0.0035,"changeRate":-0.019608,"amplitude":0.010084},"postHourTrading":{"tag":"盘后","latestPrice":0.1787,"preClose":0.1785,"latestTime":"19:41 EDT","volume":61092,"amount":10613.1326,"timestamp":1784158908905,"change":0.0002,"changeRate":0.00112,"amplitude":0.033053},"volumeRatio":0.333100264043688},"requestUrl":"/m/hq/s/JUNS/tweets","defaultTab":"tweets","newsList":[{"id":"2649980768","title":"Jupiter Neurosciences Names Former White House Economic Adviser Tomas Philipson to Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2649980768","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649980768?lang=en_us&edition=fundamental","pubTime":"2026-07-07 20:58","pubTimestamp":1783429099,"startTime":"0","endTime":"0","summary":"Jupiter Neurosciences names former White House economic adviser Tomas Philipson to boardJupiter Neurosciences appointed health care economist Tomas J. Philipson to its board, effective June 26, 2026.P","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nNDL3TydXC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2210149790.SGD","BCDF","LU2095319765.USD","NDAQ","BK4007","LU0314104364.USD","SG9999014013.SGD","IE00BN0W2V16.EUR","SG9999014039.USD","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","SG9999014021.USD","IE00BKPKM429.USD","IE00BGHQF748.EUR","SG9999014005.SGD","BK4112","LU2210150020.SGD","BK4585","IE00BN0W2T93.GBP","IE00BN0W2W23.USD","JUNS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649980294","title":"Jupiter Neurosciences Strengthens Board with Appointment of DR. Tomas J. Philipson","url":"https://stock-news.laohu8.com/highlight/detail?id=2649980294","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649980294?lang=en_us&edition=fundamental","pubTime":"2026-07-07 20:58","pubTimestamp":1783429080,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nTUA7Z5WS0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","JUNS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648562069","title":"Jupiter Neurosciences Appoints Tomas J. Philipson to Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2648562069","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648562069?lang=en_us&edition=fundamental","pubTime":"2026-07-01 05:07","pubTimestamp":1782853674,"startTime":"0","endTime":"0","summary":"Jupiter Neurosciences appoints Tomas J. Philipson to boardJupiter Neurosciences appointed health care economist Tomas J. Philipson to its board, effective June 26, 2026.Philipson runs TJP Economic Con","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nNDL4GDh8B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JUNS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647037629","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2647037629","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647037629?lang=en_us&edition=fundamental","pubTime":"2026-06-29 19:37","pubTimestamp":1782733022,"startTime":"0","endTime":"0","summary":"Farmmi  shares were down 68% in Monday premarket activity after the company announced a public offering of Class A ordinary shares.Jupiter Neurosciences  stock was down 22% after the company filed a prospectus for the resale of up to 16 million shares.Creative Realities  shares were down 19% after the company launched a public offering of common shares and pre-funded warrants.Larimar Therapeutics  stock was down 16%, following the previous session's 4.6% gain.PicoCELA  shares were down 16% after the previous session's 127% gain.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4212","LRMR","CREX","BK4020","BK4009","FAMI","JUNS","PCLA","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646459360","title":"Jupiter Neurosciences - Files for Resale of up to 16 Mln Shares by Selling Stockholder - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2646459360","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646459360?lang=en_us&edition=fundamental","pubTime":"2026-06-27 04:34","pubTimestamp":1782506076,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nFWN42Y0I8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["JUNS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645002231","title":"Jupiter Neurosciences Announces Board Member Resignation and Vacancy","url":"https://stock-news.laohu8.com/highlight/detail?id=2645002231","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645002231?lang=en_us&edition=fundamental","pubTime":"2026-06-22 20:01","pubTimestamp":1782129712,"startTime":"0","endTime":"0","summary":"Jupiter Neurosciences, Inc. ( ($JUNS) ) has issued an update. On June 17, 2026, Jupiter Neurosciences, Inc. announced that Board member Allison W. ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/jupiter-neurosciences-announces-board-member-resignation-and-vacancy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/jupiter-neurosciences-announces-board-member-resignation-and-vacancy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JUNS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645021157","title":"Jupiter Neurosciences director Allison Brady resigns from board, committees","url":"https://stock-news.laohu8.com/highlight/detail?id=2645021157","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645021157?lang=en_us&edition=fundamental","pubTime":"2026-06-22 19:31","pubTimestamp":1782127876,"startTime":"0","endTime":"0","summary":"Jupiter Neurosciences director Allison W. Brady resigned effective June 17, 2026.Brady also stepped down from the board’s audit committee and compensation committee.The resignation was not tied to any dispute over the company’s operations, policies, or practices.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jupiter Neurosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 22, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260622:nNDL7rp5Gt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","JUNS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644978089","title":"Sk Pharmteco Announces Strategic Collaboration With Orphan Therapeutics Accelerator","url":"https://stock-news.laohu8.com/highlight/detail?id=2644978089","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644978089?lang=en_us&edition=fundamental","pubTime":"2026-06-18 21:41","pubTimestamp":1781790104,"startTime":"0","endTime":"0","summary":"June 18 (Reuters) - SK Inc <034730.KS>::*SK PHARMTECO ANNOUNCES STRATEGIC COLLABORATION WITH ORPHAN THERAPEUTICS ACCELERATOR FOR THE DEVELOPMENT AND MANUFACTURING OF RARE DISEASE THERAPIES  ((Reuters ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260618:nRSD6sfRnY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","JUNS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641128068","title":"Jupiter Neurosciences Promotes Silva to COO and President","url":"https://stock-news.laohu8.com/highlight/detail?id=2641128068","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641128068?lang=en_us&edition=fundamental","pubTime":"2026-06-06 06:16","pubTimestamp":1780697773,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Jupiter Neurosciences, Inc. ( ($JUNS) ). On June 5, 2026, Jupiter Neurosciences amended the employment agreemen...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/jupiter-neurosciences-promotes-silva-to-coo-and-president?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/jupiter-neurosciences-promotes-silva-to-coo-and-president?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2211815571.USD","COO","LU2272731600.USD","BK4585","JUNS","GB00BDT5M118.USD","LU1992135399.USD","BK4007","LU1992135472.HKD","LU2272731782.SGD","BK4198","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638500966","title":"Jupiter Neurosciences commences patient enrollment in RESET trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2638500966","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638500966?lang=en_us&edition=fundamental","pubTime":"2026-05-27 20:09","pubTimestamp":1779883757,"startTime":"0","endTime":"0","summary":"Jupiter Neurosciences (JUNS) announced that patient enrollment is now underway in its Phase 2a RESET clinical trial for Jotrol in Parkinson’s Disea...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/jupiter-neurosciences-commences-patient-enrollment-in-reset-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/jupiter-neurosciences-commences-patient-enrollment-in-reset-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["JUNS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638953502","title":"Jupiter Neurosciences Announces Patient Enrollment Underway in Phase 2a Reset Trial in Parkinson’s Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2638953502","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638953502?lang=en_us&edition=fundamental","pubTime":"2026-05-27 19:30","pubTimestamp":1779881400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260527:nTUAVCXGP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["JUNS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637357982","title":"Jupiter Neurosciences closes $2 million registered direct offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2637357982","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637357982?lang=en_us&edition=fundamental","pubTime":"2026-05-22 05:15","pubTimestamp":1779398115,"startTime":"0","endTime":"0","summary":"Jupiter Neurosciences closed a registered direct offering of 7,142,858 common shares, raising gross proceeds of about $2 million.Proceeds extend cash runway to fund the company’s Parkinson’s program, including a planned Phase 2a trial.Part of the financing was used to reduce debt, improving the balance sheet and shareholder equity position.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nNDL4dp53Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","LU0314104364.USD","IE00BN0W2W23.USD","IE00B64PRP62.GBP","BK4585","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","BK4007","BK4588","LU2095319765.USD","SG9999014013.SGD","IE00BKPKM429.USD","SG9999014021.USD","LU2210150020.SGD","IE00B3QW5Z07.USD","BK4112","SG9999014005.SGD","NDAQ","JUNS","LU2210149790.SGD","IE00BGHQF748.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637576273","title":"Jupiter Neurosciences Announces Closing of $2.0 Million Registered Direct Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2637576273","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637576273?lang=en_us&edition=fundamental","pubTime":"2026-05-22 05:15","pubTimestamp":1779398100,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nTUA69LSM5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","JUNS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637542335","title":"Jupiter Neurosciences Inc - Files for Offering of 7.14 Mln Shares of Common Stock - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2637542335","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637542335?lang=en_us&edition=fundamental","pubTime":"2026-05-21 20:15","pubTimestamp":1779365753,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260521:nFWN41Y0SN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["JUNS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637182788","title":"Jupiter Neurosciences prices registered direct offering at USD 2 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2637182788","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637182788?lang=en_us&edition=fundamental","pubTime":"2026-05-21 02:38","pubTimestamp":1779302292,"startTime":"0","endTime":"0","summary":"Jupiter Neurosciences priced a registered direct offering of 7,142,858 common shares for gross proceeds of about $2 million.Closing is expected on or about May 21, 2026, subject to customary conditions.D. Boral Capital is acting as exclusive placement agent.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nNDL8WSDwd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2095319765.USD","JUNS","IE00BN0W2T93.GBP","IE00B3QW5Z07.USD","NDAQ","BK4112","IE00B64PRP62.GBP","IE00BN0W2W23.USD","SG9999014021.USD","LU2210149790.SGD","BK4585","IE00BN0W2V16.EUR","SG9999014005.SGD","LU0314104364.USD","IE00BKPKM429.USD","BK4588","LU2210150020.SGD","IE00BGHQF748.EUR","BK4007","SG9999014039.USD","SG9999014013.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637482200","title":"Jupiter Neurosciences Announces Pricing of $2.0 Million Registered Direct Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2637482200","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637482200?lang=en_us&edition=fundamental","pubTime":"2026-05-21 02:38","pubTimestamp":1779302280,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nTUANZLZV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["JUNS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636841927","title":"Jupiter Neurosciences Inc - to Buy Exclusive U.S. Rights to Ala-002 From Pharmala Biotech","url":"https://stock-news.laohu8.com/highlight/detail?id=2636841927","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636841927?lang=en_us&edition=fundamental","pubTime":"2026-05-20 19:38","pubTimestamp":1779277117,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nFWN41X0D7:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["JUNS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636841908","title":"Jupiter Neurosciences agrees to pay $3.33 million for exclusive US rights to PharmAla’s ALA-002","url":"https://stock-news.laohu8.com/highlight/detail?id=2636841908","media":"Reuters","labels":["corporation","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636841908?lang=en_us&edition=fundamental","pubTime":"2026-05-20 19:38","pubTimestamp":1779277097,"startTime":"0","endTime":"0","summary":"Jupiter Neurosciences entered a term sheet to acquire exclusive, perpetual U.S. licensing rights to PharmAla Biotech’s ALA-002, a next-generation MDMA drug candidate.The deal values the upfront consideration at USD 3.33 million, split between USD 1.5 million in cash and USD 1.83 million in common stock, with additional development milestones and single-digit royalties.ALA-002 is a patented, non-racemic MDMA formulation that the FDA has recognized as a Novel Chemical Entity, with the companies citing improved cardiovascular safety and reduced abuse liability versus racemic MDMA.Jupiter agreed to place USD 600,000 into escrow on signing, credited against the upfront cash payment at closing.The parties target signing definitive agreements within 90 days, subject to due diligence and customary approvals.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nNDL219rVf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","SG9999014013.SGD","SG9999014005.SGD","BK4112","LU0314104364.USD","IE00B3QW5Z07.USD","BK4007","IE00B64PRP62.GBP","IE00BKPKM429.USD","LU2210150020.SGD","JUNS","IE00BN0W2W23.USD","IE00BN0W2V16.EUR","LU2095319765.USD","IE00BGHQF748.EUR","SG9999014039.USD","IE00BN0W2T93.GBP","LU2210149790.SGD","BK4585","SG9999014021.USD","NDAQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635495729","title":"Jupiter Neurosciences Q1 EPS $(0.06) Misses $(0.05) Estimate, Sales $18.652K Miss $225.000K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2635495729","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635495729?lang=en_us&edition=fundamental","pubTime":"2026-05-15 05:10","pubTimestamp":1778793006,"startTime":"0","endTime":"0","summary":"Jupiter Neurosciences (NASDAQ:JUNS) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $(0.05) by 20 percent. This is a 20 percent decrease over losses of $(0.05) per share from","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52583960/jupiter-neurosciences-q1-eps-0-06-misses-0-05-estimate-sales-18-652k-miss-225-000k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Jupiter Neurosciences Q1 EPS $(0.06) Misses $(0.05) Estimate, Sales $18.652K Miss $225.000K Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JUNS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635729670","title":"Jupiter Neurosciences Q1 FY26 net loss widens 35% to $2.06 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2635729670","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635729670?lang=en_us&edition=fundamental","pubTime":"2026-05-15 05:02","pubTimestamp":1778792532,"startTime":"0","endTime":"0","summary":"Jupiter Neurosciences posted a net loss of $2.06 million for quarter ended March 31, 2026, widening 35% from year-ago period.Net revenues were $18,652, swinging from no revenue a year earlier as Nugevia product shipments began in fourth-quarter 2025.General and administrative expense climbed 46% to $1.57 million, due to higher payroll and consulting costs plus expenses related to Nugevia.Research and development expense fell 12% to $411,049 on lower clinical trial and payroll and consulting costs.Cash and cash equivalents totaled $2.36 million at March 31, 2026, while net cash used in operating activities increased to $1.43 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jupiter Neurosciences Inc. published the original content","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260514:nNDL5JTPbS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["JUNS","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.jupiterneurosciences.com","stockEarnings":[{"period":"1week","weight":-0.0742},{"period":"1month","weight":-0.242},{"period":"3month","weight":-0.5524},{"period":"6month","weight":-0.7921},{"period":"1year","weight":-0.9399},{"period":"ytd","weight":-0.825}],"compareEarnings":[{"period":"1week","weight":0.0126},{"period":"1month","weight":0},{"period":"3month","weight":0.0757},{"period":"6month","weight":0.0913},{"period":"1year","weight":0.2132},{"period":"ytd","weight":0.1069}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"exchange":"NASDAQ","name":"Jupiter Neurosciences","nameEN":"Jupiter Neurosciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.2","shortVersion":"4.45.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Jupiter Neurosciences(JUNS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Jupiter Neurosciences(JUNS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Jupiter Neurosciences,JUNS,Jupiter Neurosciences股票,Jupiter Neurosciences股票老虎,Jupiter Neurosciences股票老虎国际,Jupiter Neurosciences行情,Jupiter Neurosciences股票行情,Jupiter Neurosciences股价,Jupiter Neurosciences股市,Jupiter Neurosciences股票价格,Jupiter Neurosciences股票交易,Jupiter Neurosciences股票购买,Jupiter Neurosciences股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Jupiter Neurosciences(JUNS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Jupiter Neurosciences(JUNS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}